Catalysts

WHITE PAPERS AND CASE STUDIES

• Electronic Batch Reporting

  Learn how a CDMO automatically created a comprehensive batch report model to drive their reporting and speed root cause identification of quality failures with an Industrial DataOps software solution.

• Rescuing A Global Program For NDA Success

  Explore the collaboration that enabled FDA approval of a novel chronic-condition therapy, rescued a high-risk program, and demonstrated a unified “one-team” approach by reworking the sponsor's SAP.

• Bringing A Device From Concept To Market

  Within three years, see how this company was able to achieve FDA approval and CE Marking, facilitating its entry into the U.S. and EU markets.

• Use Of Epiontis ID In A Phase 2 Psoriasis Trial

  Mirikizumab’s Phase 2 trial explores IL-23 inhibition in psoriasis, measuring immune cell changes to assess its potential for long-term disease control and flare-up prevention.

• Leverage Apps To Reduce Line Changeover Time From 14 Days To 3

  A global biopharma leader modernized its complex equipment changeover process using an innovative platform to achieve faster execution, fewer errors, and greater visibility through digitized, validatable SOPs.

• Accelerating A Complex Molecule From CLD To cGMP In 12 Months

  Learn how to mitigate technical risk, implement parallel process development, and design custom purification strategies for highly sensitive novel modalities to accelerate to cGMP material.

• ArxZyme™ Acetone Removal For AMPAC Fine Chemicals

  AMPAC faced a critical challenge with acetone management. The high acetone levels in the effluent from its chemical processing operations required an effective industrial wastewater treatment solution to meet environmental regulations and ensure safe discharge.

• AquaNereda Provides The Lowest Total Cost Of Ownership For 10x Capacity Increase And Nutrient Removal Limits

  The Wolcott Wastewater Treatment Plant in Kansas City chose the AquaNereda technology for its capacity and cost benefits. The system improved nutrient removal and met permit requirements.

• Achieving Complete Destruction Of PFAS Using electraCLEAR Process

  In early 2023, Lacks Enterprises Inc., a large automotive component supplier in the midwestern US, engaged Axine to address destruction of legacy PFAS compounds in wastewater from its manufacturing processes.

• Changing The Clinical Feasibility Game With AI

  AI is only as good as the data it’s built upon. Our customized AI platforms are constructed on a foundation of trustworthy, carefully curated data to produce detailed, expert-driven responses.

• Boosting Recruitment Strategy For Phase III Study In Ulcerative Colitis

  Learn about the successful execution of a challenging three-arm, randomized, placebo-controlled Phase 3 study in Ulcerative Colitis despite strict inclusion criteria and a limited patient pool.

• Why A Leading Manufacturing Partner Chose NeoTOP Packaging Machines

  Learn how a leading CDMO partnered with Körber to quickly deploy a high-speed packaging solution to meet tight production deadlines in the face of a global pandemic.